ICLR — ICON PLC
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1060955 ·
Last close
$195.02
Market Cap
$15.05B
52W High
$219.04
52W Low
$66.57
ADV30
1,100,480
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 2,024,757,000 | 491,832,000 | 200,560,000 | 122,130,000 | 16,242,332,000 | 808,984,000 | 7,115,013,000 |
| Jun 2026 | 2,063,486,000 | 479,294,000 | 194,209,000 | 72,582,000 | 16,400,320,000 | 928,385,000 | 7,022,158,000 |
| Mar 2026 | 2,033,999,000 | 477,926,000 | 186,997,000 | 104,751,000 | 16,319,022,000 | 765,164,000 | 7,018,726,000 |
| Dec 2025 | 2,189,839,000 | 500,894,000 | 230,369,000 | -110,139,000 | 16,269,782,000 | 647,295,000 | 7,076,398,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,027,576,000
Investing CF
$-254,295,000
Financing CF
$-434,028,000
CapEx
$-170,512,000
Dividends Paid
—
Buybacks
$-400,000,000
EPS Diluted TTM
$5.81
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$2,021,420,000
Inventory
—
Receivables
$2,715,874,000
ST Investments
$0
EBIT TTM
$440,596,000
Pretax Income TTM
$237,531,000
Interest Exp TTM
$203,065,000
Analysts
17
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,294,416,896
EBITDA
$523,480,992
Free Cash Flow
$622,646,656
Enterprise Value
$15,660,429,312
Total Cash
$928,385,024
Total Debt
$3,525,835,008
Shares Out
77,154,209
Trailing EPS
$0.64
Book Value
$121.55
ROE
0.3%
ROA
1.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 8,251,340,000 | 1,012,459,000 | 229,339,000 | 16,269,782,000 | 7,076,398,000 | 9,193,384,000 | 1,036,205,000 |
| Dec 2024 | 8,188,990,000 | 1,154,081,000 | 739,126,000 | 16,634,822,000 | 7,193,468,000 | 9,441,354,000 | 1,286,652,000 |
| Dec 2023 | 8,054,926,000 | 994,230,000 | 554,208,000 | 16,864,783,000 | 7,653,337,000 | 9,211,446,000 | 1,161,027,000 |
| Dec 2022 | 7,741,386,000 | 866,075,000 | 505,304,000 | 17,185,278,000 | 8,687,315,000 | 8,497,963,000 | 563,315,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$11.88
Max Pain — expiry 2026-12-18
max pain strike: $135.00 · spot: $195.16 · call oi: 3,633 · put oi: 1,028
Expected Move to 2026-12-18:
±$21.65
(11.09%) —
implied range
$173.51 –
$216.81
· ATM straddle on $195.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $15.92B | $332.16 | — |
| MEDP | Medpace Holdings, Inc. | $18.27B | $653.09 | — |
| INCY | INCYTE CORP | $24.27B | $119.09 | — |
| LNTH | Lantheus Holdings, Inc. | $6.66B | $101.80 | — |
| IQV | IQVIA HOLDINGS INC. | $42.45B | $257.60 | — |
News headlines (Yahoo Finance, 1h cache)
ICON: 3 Key Takeaways for Long-Term Investors
2026-11-12 18:35 · Yahoo
ICON to Participate at Upcoming Investor Conferences
2026-11-10 14:00 · Yahoo
ICON Launches FIRECREST AI-Directed Video Engine, Changing the Economics of Site Communications
2026-11-05 13:00 · Yahoo
ICON PLC (ICLR) Is Leveraging AI to Accelerate Clinical Trials
2026-11-03 15:49 · Yahoo
ICON (ICLR) Could Be 15% Overvalued After Record Wins And Fresh Buyback
2026-10-29 07:11 · Yahoo
What Icon (ICLR) Said on Its Q3 Earnings Call
2026-10-28 17:04 · Yahoo
ICON (ICLR) Q3 2026 Earnings Call Transcript
2026-10-28 15:14 · Yahoo
ICON Public Limited Company Q3 2026 Earnings Call Summary
2026-10-28 12:30 · Yahoo
ICON (ICLR) Stock Could Be A Bargain After Cash Flow Rebound
2026-10-22 04:26 · Yahoo
Icon's 2027 Outlook Supported by Strong Bookings as Growth Questions Persist, RBC Says
2026-10-12 15:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.